Clinical Trial Update: Paricalcitol in Treating Patients With Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating paricalcitol in patients with myelodysplastic syndrome; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Paricalcitol (paricalcitol)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED